Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 1 14Phase 1/2 11Phase 3 5Phase 2/3 3Phase NA 2Phase EARLY_PHASE1 2Phase 4 2

Status

Completed 2

Sponsor Class

INDUSTRY 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Head & Neck 1Dermatologic 1

Conditions

Breast Neoplasms 276Neoplasms 202Prostatic Neoplasms 118Polycystic Ovary Syndrome 114Colorectal Neoplasms 103Carcinoma, Hepatocellular 103Carcinoma, Non-Small-Cell Lung 88Lung Neoplasms 70Stomach Neoplasms 62Precursor Cell Lymphoblastic Leukemia-Lymphoma 60Pain 59Neoplasm Metastasis 54Multiple Myeloma 52Pancreatic Neoplasms 46Keratosis, Actinic 46Head and Neck Neoplasms 43Pain, Postoperative 42Leukemia, Myeloid, Acute 40Leiomyoma 39Recurrence 38Liver Neoplasms 38Colonic Neoplasms 37Uterine Cervical Neoplasms 35Lymphoma 35Brain Neoplasms 34Infertility 33Papillomavirus Infections 32Ovarian Neoplasms 31Lymphoma, Follicular 31Lymphoma, Non-Hodgkin 30

Interventions

Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Interventional × Neoplasms, Squamous Cell × Clear all
NCT00847912 2021-06-11

VAKCCT

VA Office of Research and Development

Phase 4 Completed
954 enrolled 11 charts
Dermatologic

Carcinoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Neoplasms, Neoplasms by Site, Skin Diseases, Skin Neoplasms, Neoplasms, Basal Cell, Neoplasms, Squamous Cell

NCT01283906 2013-09-12

MuGard

Access Pharmaceuticals, Inc.

Phase 4 Completed
120 enrolled
Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Neoplasms, Squamous Cell, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡